1. Bae KC, Cho CH, Lee KJ, Son ES, Lee SW, Lee SJ, et al. Efficacy of intra-articular injection of thrombin-based hemostatic agent in the control of bleeding after primary total knee arthroplasty. Knee Surg Relat Res. 2014; 26:236–240. PMID:
25505706.
Article
2. Suzuki R, Matsuhashi M, Kuwahara T, Kase T. Topical use of thrombin in prostatic surgery. Hinyokika Kiyo. 1986; 32:1461–1464. PMID:
2436462.
3. Lawson JH. The clinical use and immunologic impact of thrombin in surgery. Semin Thromb Hemost. 2006; 32(Suppl 1):98–110.
Article
4. Clark JA, Humphries JE, Crean S, Reynolds MW. Topical bovine thrombin: a 21-year review of topical bovine thrombin spontaneous case safety reports submitted to FDA's Adverse Event Reporting System. Pharmacoepidemiol Drug Saf. 2010; 19:107–114. PMID:
20014051.
Article
5. Ortel TL, Mercer MC, Thames EH, Moore KD, Lawson JH. Immunologic impact and clinical outcomes after surgical exposure to bovine thrombin. Ann Surg. 2001; 233:88–96. PMID:
11141230.
Article
6. Streiff MB, Ness PM. Acquired FV inhibitors: a needless iatrogenic complication of bovine thrombin exposure. Transfusion. 2002; 42:18–26. PMID:
11896308.
Article
7. Chapman WC, Singla N, Genyk Y, McNeil JW, Renkens KL Jr, Reynolds TC, et al. A phase 3, randomized, double-blind comparative study of the efficacy and safety of topical recombinant human thrombin and bovine thrombin in surgical hemostasis. J Am Coll Surg. 2007; 205:256–265. PMID:
17660072.
Article
8. Ham SW, Lew WK, Weaver FA. Thrombin use in surgery: an evidence-based review of its clinical use. J Blood Med. 2010; 1:135–142. PMID:
22282693.
9. Tanaka KA, Key NS, Levy JH. Blood coagulation: hemostasis and thrombin regulation. Anesth Analg. 2009; 108:1433–1446. PMID:
19372317.
Article
10. Tadokoro K, Ohtoshi T, Takafuji S, Nakajima K, Suzuki S, Yamamoto K, et al. Topical thrombin-induced IgE-mediated anaphylaxis: RAST analysis and skin test studies. J Allergy Clin Immunol. 1991; 88:620–629. PMID:
1918728.
Article
11. Sim DW, Lee JS, Park KH, Jeong KY, Ye YM, Lee JH, et al. Accurate assessment of alpha-gal syndrome using cetuximab and bovine thyroglobulin-specific IgE. Mol Nutr Food Res. 2017; 61:1601046.
Article
12. Liang KL, Su MC, Jiang RS. Comparison of the skin test and ImmunoCAP system in the evaluation of mold allergy. J Chin Med Assoc. 2006; 69:3–6. PMID:
16447919.
Article
13. Yanagida N, Sato S, Takahashi K, Nagakura KI, Ogura K, Asaumi T, et al. Skin prick test is more useful than specific IgE for diagnosis of buckwheat allergy: a retrospective cross-sectional study. Allergol Int. Forthcoming 2017.
Article
14. Nacaroglu HT, Erdem SB, Karaman S, Dogan D, U Karkiner CS, Kanık ET, et al. Diagnostic values for egg white specific IgE levels with the skin prick test in Turkish children with egg white allergy. Allergol Immunopathol (Madr). 2017; 45:445–451. PMID:
28237131.
Article
15. Coop CA, Schapira RS, Freeman TM. Are ACE inhibitors and beta-blockers dangerous in patients at risk for anaphylaxis? J Allergy Clin Immunol Pract. 2017; 5:1207–1211. PMID:
28552379.
Article
16. Park HJ, Lee JH, Kim SR, Kim SH, Park KH, Lee CK, et al. A new practical desensitization protocol for oxaliplatin-induced immediate hypersensitivity reactions: a necessary and useful approach. J Investig Allergol Clin Immunol. 2016; 26:168–176.
Article